Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
R9Ex646K2PRfnQvG
Listen
